BMEA β€” BIOMEA FUSION INC

Ownership history in nVerses Capital, LLC  Β·  5 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in BIOMEA FUSION INC (BMEA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

nVerses Capital, LLC Γ— BMEA AI Analytics

πŸ“‰ nVerses Capital, LLC underperformed the S&P 500 by –127.1% annually on this BMEA position. Average cost basis: $10.10. Maximum drawdown during holding period: –82.2%.

πŸ“ˆ Position Alpha vs SPY
-127.1%
annualised excess return

❌ Significantly underperformed the S&P 500 by 127.1% ann.
4 quarters analyzed

πŸ’° Entry Quality
$10.10
-80.0% vs current ($2.02)

Best entry: $10.10 (2024 Q3)  Β·  Worst: $10.10 (2024 Q3)

πŸ›‘οΈ Drawdown Resilience
–82.2%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
100%
buy-side decisions

1 add Β· 0 trims. Bought during 0 of 3 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    BMEA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 5 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 100 β€” 0% 0.00% $1K $2.02
2025 Q2 UNCHANGED 100 β€” 0% 0.00% $1K $1.80
2025 Q1 UNCHANGED 100 β€” 0% 0.00% $1K $2.13
2024 Q4 UNCHANGED 100 β€” 0% 0.00% $1K $3.88
2024 Q3 INITIATED 100 β€” β€” 0.00% $1K $10.10
← Back to nVerses Capital, LLC Holdings